Pipeline problems for Wyeth
Wyeths pipeline suffered a pair of setbacks Friday as the FDA rejected Wyeths schizophrenia drug bifeprunox and safety concerns led the drugmaker to stop using a developmental Hepatitis C drug in a patient study.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.